Integra LifeSciences Holdings Corporation (IART) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
1100 Campus Road
Princeton, NJ 08540
United States of America (the)
Phone
609 275 0500
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
4396
First IPO Date
August 16, 1995
| Name | Title | Pay | Year Born |
| Stuart Essig | CEO, President & Chairman | 85,000 | 1962 |
| Mojdeh Poul | President, Chief Executive Officer & Director | 1.91M | 1963 |
| Jeffrey Mosebrook | Senior Vice President of Finance & Principal Accounting Officer | 493,138 | 1976 |
| Michael D. Hutchinson | Executive Vice President, Chief Legal Officer & Secretary | 549,518 | 1971 |
| Harvinder Singh | Executive Vice President & President of International Business | 714,613 | 1966 |
| Robert T. Davis Jr. | Executive Vice President & President of Tissue Technologies | 722,354 | 1959 |
| Lea Daniels Knight | Executive Vice President & Chief Financial Officer | 884,701 | 1972 |
| Michael J. McBreen | Chief Commercial Officer | 942,931 | 1966 |
| Christopher Ward | Senior Director of Investor Relations | 0 | N/A |
| Laurene Isip | Vice President of Global Corporate Communications & Public Relations | 0 | N/A |
| Teshtar Elavia | Corporate VP & Chief Technology Officer | 0 | N/A |
| Chantal Veillon-Berteloot | Executive Vice President & Chief Human Resources Officer | 0 | 1971 |
| Jessica Smith | Corporate VP & Global Quality and Chief Regulatory Officer | 0 | N/A |
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.